Akari Therapeutics

AKTXNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.253 M

$7.00 -13.37%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$17.3M

Loss-making

Shares outstanding

91,567,009,533

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#422Psyence BiomedicalPBM$13.2M
#423Vistagen TherapeuticsVTGN$12.8M
#424Akari TherapeuticsAKTX$12.3M
#425Phio PharmaceuticalsPHIO$12.1M
#426BioLineRxBLRX$11.8M

Where these numbers come from

Share counts and financials for Akari Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.